Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Opioid Manag ; 10(4): 277-83, 2014.
Article in English | MEDLINE | ID: mdl-25162607

ABSTRACT

Buprenorphine is approved by the Food and Drug Administration for the treatment of chronic pain in low-dose transdermal patch formulations and for the treatment of addiction in high-dose sublingual tablets and films. Clinicians often prescribe these high-dose preparations "off label" for pain management. In the workers' compensation setting, it is particularly important to consider factors such as a) if the injured person has, and is being treated for co-occurring addiction as well as pain; b) if alternative therapies, including opioid withdrawal, were considered prior to initiating buprenorphine treatment; and c) the anticipated duration of treatment. This article reviews buprenorphine's approved indications, formulations, pharmacology, clinical efficacy, and special considerations in the workers' compensation setting.


Subject(s)
Analgesics, Opioid/therapeutic use , Buprenorphine/therapeutic use , Occupational Diseases/drug therapy , Occupational Health , Workers' Compensation , Administration, Sublingual , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Analgesics, Opioid/chemistry , Buprenorphine/administration & dosage , Buprenorphine/adverse effects , Buprenorphine/chemistry , Drug Administration Schedule , Drug Approval , Humans , Occupational Diseases/diagnosis , Occupational Diseases/etiology , Off-Label Use , Opioid-Related Disorders/etiology , Opioid-Related Disorders/prevention & control , Patient Selection , Risk Assessment , Risk Factors , Tablets
2.
J Psychoactive Drugs ; 44(2): 119-24, 2012.
Article in English | MEDLINE | ID: mdl-22880539

ABSTRACT

Chronic pain is commonly treated by prescribing an opioid medication. For those suffering from both chronic pain and substance dependence, barriers to adequate pain management increase. This often causes both disorders to exacerbate one another. Effective treatment may also be hampered by opioid-induced hyperalgesia, tolerance, physical dependence, "chemical coping," and diminished physical and emotional functioning. This article reviews current research trends, potential problems stemming from prescription opioid use, and suggestions for clinical practice.


Subject(s)
Analgesics, Opioid/adverse effects , Chronic Pain/drug therapy , Substance-Related Disorders/rehabilitation , Adaptation, Psychological , Chronic Pain/epidemiology , Chronic Pain/psychology , Comorbidity , Drug Tolerance , Emotions , Guideline Adherence , Humans , Hyperalgesia/chemically induced , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/rehabilitation , Patient Selection , Practice Guidelines as Topic , Practice Patterns, Physicians' , Risk Assessment , Risk Factors , Self Medication , Substance-Related Disorders/epidemiology , Substance-Related Disorders/psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...